Bhaswat ChakrabortyPhD, B.Pharm
Dr. Bhaswat S. Chakraborty graduated with a B.Pharm. (Hons.) from Banaras Hindu University and a PhD in Clinical Pharmacology from University of Saskatchewan
Following his post doctoral fellowship and a brief spell of teaching at University of Saskatchewan, Saskatoon, Canada, Dr. Chakraborty joined the Health Protection Branch, Ministry of Health, Government of Canada (Canadian FDA) in Ottawa and served as a Senior Clinical Reviewer and Acting Department Head of the New Drug Applications. In this role, he has evaluated more than 300 Abbreviated New Drug Applications and 20 Pharmacokinetics based New Drug Applications.
Thereafter, he was the Director of Biopharmaceutics at Biovail Corporation International, Toronto. Till date, he has designed and investigated ~624 Phase I and 62 higher Phase Clinical Studies for the FDA, TPP, EU and other Agencies. Recipient of many prestigious research grants, Dr. Chakraborty is currently the Senior Vice President and Chairman of Research & Development Science Core Committee at Cadila Pharmaceuticals Ltd., Ahmedabad. He is also an author and co-author of more than 100 scientific papers and abstracts in refereed international journals. An eminent speaker, Dr. Chakraborty is an Honorary Professor and External Examiner to a few universities; editorial board member of three international journals; reviewer of many professional journal manuscripts, and also on the board of several Institutes and Universities in India and USA in various capacities. He has supervised 24 Masters’ and 5 PhD students